tirzepatide dosing compared to semaglutide vs Tirzepatide: Head-to-Head for Weight Loss & Diabetes Weight loss is not one

BackgroundClinical obesity is a prevalent chronic disease, significantly increasing morbidity and mortality while impairing quality of life

Available only after consultation with a licensed clinician

Introduction Clinical trials have demonstrated greater glycemic control and weight loss with once-weekly (OW) semaglutide versus other anti-diabetes medications, including sodium-glucose co-transporter 2 inhibitors (SGLT2is) in adults with type 2 diabetes (T2D), yet real-world evidence is limited

Semaglutide begins working within hours, but noticeable weight loss typically emerges between weeks 4 and 8 of consistent treatment

Weight loss plateaus can be frustrating, especially if you're struggling to identify the cause